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Background: In this retrospective study, we measured the frequency of unexpected antibodies in the blood. Specific 
considerations for preoperative preparations were kept in mind for the patients undergoing surgery positive for these 
antibodies. 
Methods: After reviewing the results of antibody screening tests lasted for 2 years, the frequency of unexpected 
antibodies was determined. Surgical patients who were positive for unexpected antibodies were selected and 
divided into two groups based on their potential need for an intra-operative transfusion (groups with high versus low 
possibility of transfusion). Blood for the high possibility group was prepared before surgery. For the low possibility 
group for which preoperative blood preparation was not performed, cases of this group were reviewed whether a 
blood preparation was delayed or not in case of transfusion. 
Results: Among a total 22,463 cases, 340 (1.52%) had positive results for antibody screening tests. Among the 243 
patients who were positive for unexpected antibodies, Lewis, Rh, Xga, and mixed antibodies were found in 85, 25, 
five, and eight cases, respectively. Out of 243 patients, 117 patients, specificities of the unexpected antibodies were 
not determined and 125 (51.4%) had a history of pregnancy and delivery, and 49 (20.2%) had a history of transfusion. 
In the low probability group, transfusions were administered for nine patients; transfusion was delayed for two 
patients due to difficulties with obtaining matched blood.
Conclusions: Patients with unexpected blood antibodies may be at increased risk for delayed transfusion. For rapid 
transfusion, it might be helpful to keep a record about blood antibodies and introduce a notification system such 
as medical alert cards. Preoperative blood preparation is needed for timely intraoperative transfusion. (Korean J 
Anesthesiol 2012; 62: 412-417)
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Introduction
One of the most important issues for patient care during 
anesthesia is managing bleeding. For this, it is important 
to know the patient’s pre-operative hemoglobin levels and 
coagulation function, as well as the status of important 
organs. Based on this information, the appropriate amounts 
of fluids and blood to be administered during surgery can be 
determined. When managing bleeding, the first concern is to 
reduce the amount of bleeding during surgery while the second 
concern is to mitigate complications associated with transfusion 
[1]. For the latter, it is important to be aware of the existence and 
specific characteristics of unexpected antibodies identified in 
the patient. 
Unexpected antibodies are sometimes referred to as irregular 
antibodies because their existence and type are unknown 
before conducting a antibody screening test. This category 
of antibodies includes most blood type antibodies excluding 
ABO and some P blood type antibodies [2]. Depending on 
the type of antibody, some develop naturally in patients but 
most unexpected antibodies are formed as part of the immune 
response after exposure to foreign antigens during pregnancy 
or transfusion. These antibodies can cause acute and delayed 
hemolytic transfusion reactions; there are many reports of such 
cases [3,4]. It is therefore important to conduct test to screen for 
and identify unexpected antibodies before transfusion. 
For patients who require transfusions, it is vital to conduct 
pre-operative testing to minimize complications and improve 
transfusion safety. For these reasons, it is essential to know 
the frequency and distribution of unexpected antibodies 
among South Koreans for prompt and safe transfusion [2]. 
The purpose of this study was to examine the frequency and 
type of unexpected antibodies found by antibody screenings 
conducted in our hospital from 2009 to 2010. In addition, we 
examined problems and issues associated with transfusion 
when unanticipated bleeding occurs in patients who are 
positive for unexpected antibodies. 
Materials and Methods
In Sanggye Paik hospital, 22,436 tests to screen for un-
expected antibodies were conducted from 2009 to 2010. Data 
were examined to calculate the frequency of unexpected 
antibodies. The unexpected antibody test results for 243 
surgical patients who were positive in the screening were then 
examined. Information about the gender, pregnancy history, 
parity, and transfusion history of these patients was collected 
from the electronic medical records of the hospital. The 243 
surgical patients who were positive for unexpected antibodies 
were divided into a high possibility group and a low possibility 
group for transfusion based on the likelihood of 500 ml of 
predicted blood loss. Additionally, the availability of matched 
blood before surgery and whether an actual transfusion 
occurred were determined. 
Unexpected antibody screening test
A quantitative test was performed using the Ortho BioVue 
microcolumn agglutination system (Ortho-Clinical Diagnostics, 
Raritan, NJ, USA). The test was performed according to the 
manufacturer’s instructions. 
Unexpected antibody identification test
When the screening test results were positive, an unexpected 
antibody identification test was performed with a microcolumn 
agglutination system using ID-Diapanel I, II (DiaMed, Murten, 
Switzerland) and LISS/Coombs cards (DiaMed). 
Results
Frequency of unexpected antibodies
Among a total of 22,436 cases for which unexpected antibody 
screening tests were conducted, 340 (1.52%) were positive. The 
number of positive patients according to year was 116 (1.13%) 
for 2009 and 127 (1.04%) for 2010. The proportions of positive 
screening results were similar despite an increase in the 
number of subjects (Table 1). Among the patients positive for 
un  expected antibodies, 243 were patients underwent surgery. 
The gender, parity history, and transfusion history of these 
individuals are shown in Table 2. 
Table 1. Frequency of Unexpected Antibodies 
Year
No. of  
patients
No. of patient with  
unexpected antibodies
No. of patients with unexpected  
antibodies undergoing surgery
2009
2010
Total
10,267
12,169
22,436
129 (1.26%)
211 (1.73%)
340 (1.52%)
116 (1.13%)
127 (1.04%)
243 (1.08%)
Data are expressed as the number (percentage).414 www.ekja.org
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Type and distribution of unexpected antibodies
The results of the unexpected antibody identification tests 
conducted for the 243 surgical patients showed that the Lewis 
antibody had the highest frequency (30.44%) followed by anti-
Le antibody (21.81%). The frequencies of Rh antibodies were 
7.41% for anti-E, 2.47% for anti-D, and 0.41% for anti-C. Two 
or more antibodies were found together in 3.29% of cases; one 
person had only autoantibodies while another individual had 
both autoantibodies and alloantibodies. Unexpected antibodies 
were not accurately identified in 48.14% of the cases (Table 3).
Availability of matched blood and actual performance 
of transfusion according to predicted blood loss 
during surgery
Out of the 243 surgical patients who were positive for 
unexpected antibodies, 43 (17.7%) were in the high possibility 
group and 200 (82.3%) were in the low possibility group. In the 
high possibility group, there were no cases for which matched 
blood was not prepared before surgery. Matched blood was not 
prepared for the low possibility group before surgery; situations 
that required transfusion occurred for nine patients in this 
group (Table 4). For seven cases, there were no difficulties with 
securing matched blood, but difficulties in securing matched 
blood were encountered for the other two cases. One of these 
cases was a patient with no underlying diseases other than 
anemia with an Hb of 8.0 g/dl before surgery that decreased to 
7.0 g/dl during surgery. Matched blood could not be obtained 
for this individual, so surgery continued with the patient 
receiving only fluid therapy. Since there was no continuous 
blood loss, surgery was completed without transfusion. After 
the completion of surgery, an Hb of 7.0 g/dl was maintained, 
and there were no major changes in vital signs and no specific 
complications. 
The other patient did not have any underlying diseases, but 
had received a transfusion of 11 units of packed red blood cells 
during an abdominal operation approximately 2 months prior 
to our study. At the time of transfusion, the antibody screening 
test results were negative. The patient underwent abdominal 
surgery to treat an enterocutaneus fistula, and the operation 
protocol included Whipple’s procedure. During the procedure, 
excessive bleeding occurred and packed red blood cells were 
ordered. However, the blood bank reported that matched blood 
was not available. As a result, the patient’s Hb decreased to 4.7 
g/dl, and total blood loss reached 3,000 ml. After 3 hours and 
30 minutes, 8 units of packed red blood cells that showed the 
weakest cross-matching reaction were obtained. Five of these 
units were transfused while the patient was carefully monitored 
for any transfusion-related complications. The procedure was 
completed without any problems and no specific complications 
developed after surgery. 
The two cases mentioned above involved patients who received 
transfusions and were negative for unexpected antibodies. For 
both individuals, difficulties in securing matched blood during 
Table 2. Characteristics of 243 Patients with Unexpected Antibodies 
who Underwent Surgery 
                   Characteristics
No. of 
patients
%
Gender
History of pregnancy and delivery
History of transfusion
Male
Female
Positive
Negative
Positive
Negative
102
141
125
118
49
194
41.96
58.04
51.44
48.56
20.16
79.84
Table 3. Classification of Detected Unexpected Antibodies in 243 
Patient who Underwent Surgery 
Antibody specificity
No. of 
patients
%
Rh
    Anti-C
    Anti-D
    Anti-E
Lewis
    Anti-Le a
    Anti-Le b
MNSs
    Anti-M
Xga
    Anti-Xga
Others
    Anti-P1
Mixed antibodies
    Anti-Le a + Le b
    Anti Le a + ?*
    Anti E + ?*
Combined with an autoantibody
    Autoantibody
    Autoantibody and non-specific antibody
Unidentified
    Non-specific antibody
    Unidentified (all positive)
Total
1
6
18
53
21
11
1
4
3
4
1
1
1
108
9
243
0.41
2.47
7.41
21.81
8.64
4.53
0.41
1.65
1.23
1.65
0.41
0.41
0.41
44.44
3.70
100
*unable to identify antibody.
Table 4. Number of Patients Who Received Intraoperative Transfusions 
High probability of 
transfusion group 
Low probability of 
transfusion group
No. of patients 
Transfusion  
    Yes
    No
43 
33 (76.74%)
10 (23.26%)
200 
     9 (4.5%)
191 (95.5%)
Data are expressed as the number of patients or percentage.415 www.ekja.org
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surgery were encountered. Thus, transfusion was delayed. 
Through additional screening performed after surgery, both 
patients were identified as positive for unexpected antibody. 
One was found to have both autoantibodies and alloantibodies 
while the other had only autoantibodies. 
Discussion
It is generally known that there are large differences in the 
frequency and type of unexpected antibodies found during 
screening according to the research subjects, blood type, 
genotypic frequency, screening method, and ability of the 
decoder [5]. The frequency of unexpected antibodies is reported 
to be 1.35% in Denmark [6], 0.78% in Germany [7], and 0.3-2% 
in the USA [8,9]. In South Korea, the frequency of unexpected 
antibodies was reported to be 1.57% by Lee et al. [10], 0.51% by 
Park et al. [11], and 0.58% by Han et al. [12]. Without considering 
differences in research subjects, the mean frequency of positive 
results obtained for South Koreans based on the above research 
results is approximately 0.84%. The high frequency reported by 
Lee et al. is thought to be related to the fact that approximately 
96% of the research subjects in this study had undergone 
pregnancy and transfusion. The patients in our study also 
showed a high frequency of 1.52%, which is thought to be due 
to their high rates of pregnancy, parity of the research subjects, 
and improvement in screening techniques. 
If positive antibody screening results are obtained before 
transfusion, an antibody identification test is conducted to 
determine the antibody specificity. If the specificity of the 
antibody is identified, then the percentage of available blood 
that is negative for the relevant antibody is calculated. For 
example, if anti-E is found, it can be estimated that 1 out of 2 
units of blood in South Korea will be negative for the antibody. 
If anti-e antibody is present, it can be estimated that 1 out of 
10 units of blood will be negative for the antibody. If 3 units 
of blood are to be transfused, 6 or more units of ABO- and 
Rh-appropriate blood should be prepared for anti-E-positive 
patients, while 30 or more units of ABO- and Rh-appropriate 
blood should be prepared for anti-e-positive patients. Then, 
blood that is negative for the relevant antibody must be found 
by testing with commercialized antibody reagents. The negative 
blood is then cross-matched with the patient’s serum, and if it 
is observed to be suitable, the blood is secured for transfusion 
[2]. Therefore, when excessive blood loss is anticipated during 
surgery, matched blood must be obtained before the operation 
for prompt and safe transfusion. For cases in which finding 
matched blood is difficult, such as ones involving individuals 
with anti-e antibodies, the amount of blood loss during surgery 
should be predicted for the preparation process. 
Alloimmunization responses to red blood cell antigens occur 
when unexpected antibodies develop after exposure to red 
blood cell antigens that are foreign to the patient [2]. This can 
occur due to transfusion or pregnancy. Additionally, antibody 
formation can occur due to an anamnestic response when 
there is repeated exposure to the same red blood cell antigen. 
Antibodies are not formed weeks or even months after initial 
exposure to foreign red blood cell antigens. Depending on the 
repeated exposure to the antigen, antibodies can rapidly appear 
within 48-72 hours after transfusion and reach a maximum 
7-10 days later [5,13]. Among the types of alloimmunization 
responses, a hemolytic response to the newly formed antibody 
is classified as a delayed hemolytic reaction while an absence of 
hemolysis is classified as a delayed serologic reaction. 
According to existing international report, the rate of detection 
of unexpected antibodies after transfusion in healthy people is 
approximately 1-1.6% [13]. Retrospective analysis of reports 
from Korea medical institutions showed that the detection rate 
of unexpected antibodies is about 0.46-1.5% [10,12,14-19]. Park 
et al. [20] determined that the rate of unexpected antibodies 
after transfusion was 0.89%. 0.81% of unexpected antibody-
negative patients became positive for these antibodies following 
transfusion while 3.38% of unexpected antibody-positive 
patients were found to develop more of these antibodies after 
transfusion. 
The Lewis antibody, which was the most frequently identified 
antibody in our study, is an IgM antibody which cannot pass 
through the placenta and so is unrelated to hemolytic disorders 
in newborns. This antibody, which is detected through direct 
agglutination, can occasionally cause hemolytic complications 
associated with transfusion and is frequently found in expectant 
mothers with no great clinical significance [19]. However, Han 
et al. [21] determined that anti-Le a, which is a type of Lewis 
antibody, causes delayed hemolytic reactions. The facts that 
Anti-Le a antibodies are mostly formed not from immune 
response but spontaneously, and that the patient in their case 
had no history of pregnancy or transfusion were cited as the 
reasons for their conclusion. 
Anti-K, which is has been found at high frequencies in 
countries other than South Korea, is a significant alloantibody 
which can cause hemolytic disease of newborns or serious 
transfusion complications [22]. Formation of this antibody 
is mainly due to transfusion or pregnancy, and although its 
frequency is reported to be low among South Koreans [23] and it 
was not identified in our study. The reason for this finding is that 
despite the consistency red blood cell antigen immunogenicity, 
the antigen cultivation rate can vary significantly according 
to ethnicity. For example, 9.0% of Caucasians are positive for 
K antigen, while only 0.5% of South Koreans are positive for 
this antigen; thus, the formation of anti-K antibody following 
transfusion or pregnancy in South Koreans is relatively rare [2]. 416 www.ekja.org
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Unexpected antibodies that exist at low titers may not be 
detected by pre-transfusion tests, but may cause unexpected 
hemolytic responses due to the transfusion of red blood cells 
that react with the antibodies. In addition, antibody titers can 
increase due to secondary immune responses, which can 
cause serious hemolytic transfusion complications during a 
subsequent transfusion. To reduce the occurrence of delayed 
hemolytic reactions, blood samples should be collected 
and tested every 72 hours for patients who need multiple 
transfusions, or a highly sensitive testing method should be 
used for the pre-transfusion test [24]. 
The decision of administer transfusions to patients with 
autoimmune hemolytic anemia are made according to the 
patient’s response to hemolysis, the cause of immunohemolytic 
anemia, and the type of antibodies that lead to this condition. 
Patients with no history of pregnancy or transfusion are 
unlikely to have alloantibodies other than autoantibodies, 
and so suitable blood for transfusion can be selected without 
conducting an autoantibody absorption test (ZZAP test). 
However, judging from the discovery of alloantibodies in 209 out 
of 647 patients (32.30%) with autoimmune hemolytic anemia 
[25], the co-existence of alloantibodies should be kept in mind 
when selecting matched blood for patients who have received 
multiple transfusions or females who have given birth more 
than once [2]. In our study, a ZZAP test [26] was performed on 
two patients who had a history of transfusion and were positive 
for unexpected antibodies. This confirmed the co-existence 
of alloantibodies and autoantibodies. Only autoantibodies 
were identified in one of the patients while the other had both 
alloantibodies and autoantibodies. 
It is difficult to differentiate autoantibodies from alloanti-
bodies because most red blood cells and autoantibodies react. 
The effort to find matched blood is necessary when alloanti-
bodies and autoantibodies co-exist, but there is almost no 
need to find matched blood when only autoantibodies exist 
[2]. Hence, most blood banks transfuse red blood cells that 
show the lowest degree of response in cross-matching tests 
for patients with only autoantibodies. For individuals with 
both auto- and alloantibodies, red blood cells negative for the 
relevant antigen that show the smallest response are transfused. 
In the latter case, it can be difficult to promptly find matched 
blood, so the anesthesiologist must identify the existence of 
unexpected antibodies before surgery, and ensure prompt and 
safe transfusion through close cooperation with the surgeon 
and blood bank. 
The main purposes of transfusion are to enhance oxygen 
trans  portation, maintain appropriate blood volume, and pro-
vide coagulation factors. Among these factors, enhancement 
of oxygen transportation is the most important. Timing the 
administration of homologous blood is usually determined 
based on hemoglobin or hematocrit levels. Factors involved in 
this judgment include the patient’s cardiovascular state, age, 
anticipated additional blood loss, arterial blood oxygenation, 
PO₂ in mixed venous blood, cardiac output, and total blood 
volume [27]. Healthy adults do not require transfusion until 
Hb decreases to 6 g/dl, but patients with underlying conditions 
such as coronary or chronic lung diseases need transfusions 
even when Hb is as high as 10 g/dl [28]. 
The two patients in our study whose transfusions were 
delayed were healthy individuals with no specific underlying 
diseases. However, transfusions were ordered because their 
clinical status indicated the need for transfusion. Difficulties 
with securing matched blood based on cross-matching 
were encountered. As a result, one of the patients received a 
trans  fusion of packed red blood cells that showed the least 
cross-matching response. This individual recovered without 
developing transfusion-associated complications or other 
effects. Although transfusion was delayed in both of these 
patients due to difficulties in securing matched blood, no 
specific complications developed because the patients were 
young and had no underlying diseases. However, patients 
with ischemic heart conditions such as coronary, lung, 
or cerebrovascular diseases are highly likely to develop 
complications due to delays in transfusion. 
For patients positive for unexpected antibodies, blood 
that does not have antigens which can cause an anamnestic 
response should be selected and transfused [29]. Some 
medical institutions issue medical alert cards containing 
this information for patients to present when hospitalized or 
undergoing transfusion [5]. Clinically significant alloantibodies 
already formed in the blood can cause hemolytic reactions 
during transfusions or pregnancies, so caution is necessary. 
Therefore, medical institutions should maintain permanent 
records of patients who produced unexpected antibodies 
due to an alloimmunization response to ensure safe and 
prompt transfusion. Issuing medical alert cards containing 
this information, which can be presented at other medical 
institutions, should also be introduced. 
Fortunately, antibody formation due to anamnestic responses 
generally causes only delayed serologic reactions [5,13]. In 
some patients, however, high antibody titers and large red blood 
cell transfusion volumes can induce hemolytic reactions. The 
reported frequency of hemolysis is one case in 5,000-11,000 
transfusions, which represents 0.05-0.07% of patients who 
receive transfusions [5]. Therefore, when there is a sudden 
need for transfusion due to acute bleeding during surgery, the 
anesthesiologist should consider the possibility of complications 
and risks from transfusion delays. This is particularly important 
for patients with unexpected antibodies for whom there could 
be difficulties in finding matched blood for transfusion. 417 www.ekja.org
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